Veeva Systems Stock

Veeva Systems Revenue

The The revenue of Veeva Systems (VEEV) as of Sep 14, 2026 is 3.20 B USD. In the previous year, The revenue was 2.75 B USD — a change of 16.34% (higher).

Revenue

3.20 BUSD

YoY

16.34%

Last updated:

In 2026, Veeva Systems's sales reached 3.20 B USD, a 16.34% difference from the 2.75 B USD sales recorded in the previous year.

Revenue has compounded at 40.9% per year over the past 16 years to 3.20 B USD.

The Veeva Systems Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
Date
Revenue
Jan 1, 2024
2.36 B USD
Jan 1, 2025
2.75 B USD
Jan 1, 2026
3.20 B USD
Jan 1, 2027 (e)
3.69 B USD
Jan 1, 2028 (e)
4.14 B USD
Jan 1, 2029 (e)
4.65 B USD
Jan 1, 2030 (e)
5.14 B USD
Jan 1, 2031 (e)
5.78 B USD
The Veeva Systems Revenue history
YEARRevenueYoY
est5.78 BUSD+12.42%
est5.14 BUSD+10.51%
est4.65 BUSD+12.19%
est4.14 BUSD+12.29%
est3.69 BUSD+15.48%
3.20 BUSD+16.34%
2.75 BUSD+16.20%
2.36 BUSD+9.68%
2.16 BUSD+16.44%
1.85 BUSD+26.33%
1.47 BUSD+32.70%
1.10 BUSD+28.05%
862.21 MUSD+24.86%
690.56 MUSD+26.93%
544.04 MUSD+32.95%
409.22 MUSD+30.65%
313.22 MUSD+49.05%
210.15 MUSD+62.22%
129.55 MUSD+111.47%
61.26 MUSD+110.31%
29.13 MUSD+120.67%
13.20 MUSD
Access this data via the Eulerpool API

Veeva Systems Revenue

Veeva Systems Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
2.36 B USD
429.33 M USD
525.71 M USD
Jan 1, 2025
2.75 B USD
691.44 M USD
714.14 M USD
Jan 1, 2026
3.20 B USD
916.37 M USD
908.91 M USD
Jan 1, 2027 (e)
3.69 B USD
1.82 B USD
1.52 B USD
Jan 1, 2028 (e)
4.14 B USD
2.00 B USD
1.69 B USD
Jan 1, 2029 (e)
4.65 B USD
2.23 B USD
1.90 B USD
Jan 1, 2030 (e)
5.14 B USD
2.51 B USD
2.09 B USD
Jan 1, 2031 (e)
5.78 B USD
2.85 B USD
2.37 B USD

Veeva Systems Margins

Veeva Systems stock margins

The Veeva Systems margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Veeva Systems. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Veeva Systems.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
71.35 %
18.16 %
22.24 %
Jan 1, 2025
74.53 %
25.17 %
26.00 %
Jan 1, 2026
75.53 %
28.68 %
28.44 %
Jan 1, 2027 (e)
75.53 %
49.42 %
41.14 %
Jan 1, 2028 (e)
75.53 %
48.26 %
40.74 %
Jan 1, 2029 (e)
75.53 %
48.01 %
40.80 %
Jan 1, 2030 (e)
75.53 %
48.91 %
40.67 %
Jan 1, 2031 (e)
75.53 %
49.36 %
41.04 %

Veeva Systems Stock analysis

What does Veeva Systems do? The history of Veeva Systems Inc: Veeva Systems is a leading company in the field of cloud software for the life science industry. The company was founded in 2007 and is headquartered in Pleasanton, California. Veeva was created by Peter Gassner and Matt Wallach to improve the management of clinical trials and collaboration in the pharmaceutical industry. Business model of Veeva Systems Inc: The business model of Veeva Systems is focused on improving efficiency and collaboration in the life science industry. The company offers cloud-based software solutions tailored to the needs of life science companies. These solutions include CRM systems, clinical trial management software, data management tools, and analytics tools. Veeva Systems was founded as a CRM company for the life science industry. With its first software, Veeva CRM, the company revolutionized how pharmaceutical companies manage and collaborate with their sales forces. Since then, Veeva Systems has expanded its portfolio and offers a wide range of software solutions, ranging from planning and conducting clinical trials to collecting and analyzing data. Divisions of Veeva Systems Inc: Veeva Systems is divided into three divisions: 1) Commercial Cloud: This division of Veeva Systems provides software solutions for managing customer relationships, sales and marketing activities, and digital marketing for life science companies. 2) Vault: The Vault division of Veeva Systems offers software solutions for managing content, data, and processes involved in clinical trials and other research projects. 3) Data Cloud: This division offers analytics and data management tools that enable life science companies to collect, manage, and analyze their data. Products of Veeva Systems Inc: Veeva CRM: A CRM software solution that allows pharmaceutical companies to control and manage their sales and marketing activities. Veeva Vault: A suite of software solutions that facilitate the management of clinical trials and research projects. Vault provides solutions for electronic data capture, electronic informed consent forms (eICFs), clinical data management, and document management. Veeva Network: A cloud-based platform that enables life science companies to simultaneously collect patient data and advertise for it. Veeva OpenData: A database of contacts and companies from the life science industry that is regularly updated. Veeva Align: A tool for optimizing personnel deployment and ensuring compliance in the sales of life science companies. Veeva Vault QualityOne: A platform for managing quality control processes, including supply chain monitoring, compliance with regulations, and ensuring standards. Conclusion: Veeva Systems has positioned itself as a leading provider of cloud software solutions for the life science industry and offers its portfolio of CRM, clinical trial management, data management, and analytics tools. The company has succeeded in improving collaboration in the pharmaceutical industry by leveraging cloud technologies to increase effectiveness, safety, and compliance. Veeva Systems is one of the most popular companies on Eulerpool.

Revenue Details

Understanding Veeva Systems's Sales Figures

The sales figures of Veeva Systems originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Veeva Systems’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Veeva Systems's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Veeva Systems’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Veeva Systems stock

The revenue of Veeva Systems is 3.20 B USD in 2026.

The revenue of Veeva Systems changed from 2.75 B USD to 3.20 B USD, representing a 16.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The revenue Veeva Systems since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's Veeva Systems historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Veeva Systems

All Key Metrics — Veeva Systems